PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Group 1 - PepGen Inc. has successfully closed its underwritten public offering of 35,937,500 shares of common stock [1] - The offering included the full exercise of the underwriters' option to purchase an additional 4,687,500 shares [1] - The company is focused on developing next-generation oligonucleotide therapies aimed at treating severe neuromuscular and neurological diseases [1]